Home › Stocks › APUS › Changes

Who bought & sold APUS (Q3 2026)

Funds holding (Q3 2026)9
New positions4
Added0
Reduced5
Exited3

As of Q3 2026, 9 institutional funds reported holding APUS (APIMEDS PHARMACEUTICALS US I): 4 opened new positions, 0 added, 5 trimmed and 3 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.

New positions (4)

Fund Shares Value Weight
HRT FINANCIAL LP New 29.51K $147.00K —
Ankerstar Wealth, LLC New 15 $75 —
Citigroup Inc New 1 $5 —
JPMorgan Chase & Co New 1 $5 —

Added to positions (0)

No adds this quarter.

Reduced positions (5)

Fund Shares Value Weight Change
Hemenway Trust Co LLC 27.40K $137.00K 0.0 -246.60K sh (-90.0%)
VANGUARD CAPITAL MANAGEMENT LLC 5.16K $25.81K — -58.49K sh (-91.9%)
VANGUARD FIDUCIARY TRUST CO 2.40K $12.02K — -21.64K sh (-90.0%)
UBS Group AG 6.43K $32.15K — -5.39K sh (-45.6%)
Tower Research Capital LLC (TRC) 1.38K $6.91K — -282 sh (-16.9%)

Exited positions (3)

Held in the prior quarter but not reported in the latest filing.

Fund Shares Value Weight
GEODE CAPITAL MANAGEMENT, LLC Exited 35.11K $31.60K —
Geode Capital Management Exited 35.11K $31.60K —
JANE STREET GROUP, LLC Exited 15.99K $14.39K —